Skip to main content
. 2020 Mar 31;27(1):96–104. doi: 10.1016/j.cmi.2020.03.023

Table 1.

Baseline characteristics included patients (n = 2957)

Demographics Patients (n = 2957)a
Age (years) 50 (36-63)
Gender (male) 1195 (40.4%)
Caucasian ethnicity 2862 (96.8%)
Comorbiditiesb
 COPD 176 (6.0%)
 Asthma 307 (10.4%)
 Other lung disease 62 (2.1%)
 Heart failure 57 (1.9%)
 Ischemic heart disease 159 (5.4%)
 Other hearth disease 111 (3.8%)
 Diabetes 190 (6.4%)
Smoking past or current 1603 (54.2%)
Disease related characteristics at presentation
Severe cough 983 (33.2%)
Sputum production 309 (10.4%)
Shortness of breath 215 (7.3%)
Wheeze 115 (3.9%)
Blocked or runny nose 355 (12.0%)
Fever 122 (4.1%)
Chest pain 155 (5.2%)
Muscle aching 163 (5.5%)
Headache 226 (7.6%)
Disturbed sleep 542 (18.3%)
Feeling generally unwell 349 (11.8%)
Interference with normal daily activities 344 (11.6%)
Confusion/disorientation 6 (0.2%)
Diarrhoea 16 (0.5%)
One or more abnormalities at lung auscultation 1165 (39.4%)
Breaths (per min) 16 (15-18)
Heart rate (beats per min) 76 (70-83)
Systolic blood pressure (mmHg) 127 (117-140)
Diastolic blood pressure (mmHg) 80 (70-85)
Oral temperature (°C) 36.7 (36.4-37)
Medication prescribed for illnessc 2086 (70.5%)

COPD, chronic obstructive pulmonary disease.

a

Demographics are given as absolute numbers with % for categorical variables or as median with interquartile range for continuous variables.

b

Some patients had multiple comorbidities.

c

Prescribed medication included antibiotics, antitussives, mucolytic drugs, antihistamines, bronchodilators and anti-inflammatory drugs.